相似文献
1
Clinical Trials in Pancreatic Cancer: A Long Slog.
Oncologist. 2017 Dec;22(12):1424-1426. doi: 10.1634/theoncologist.2017-0453. Epub 2017 Oct 5.
2
Perioperative Clinical Trials for Pancreatic Cancer in the National Clinical Trials Network.
Ann Surg Oncol. 2019 Dec;26(13):4173-4174. doi: 10.1245/s10434-019-07767-0. Epub 2019 Sep 24.
3
Pancreatic cancer clinical trials and accrual in the United States.
J Clin Oncol. 2013 Sep 20;31(27):3432-8. doi: 10.1200/JCO.2013.49.4823. Epub 2013 Aug 19.
4
Timely completion of scientifically rigorous cancer clinical trials: an unfulfilled priority.
J Clin Oncol. 2013 Sep 20;31(27):3312-4. doi: 10.1200/JCO.2013.51.3192. Epub 2013 Aug 19.
5
Genomic research advances pancreatic cancer's early detection and treatment.
J Natl Cancer Inst. 2015 Jul 3;107(7). doi: 10.1093/jnci/djv195. Print 2015 Jul.
6
Pancreatic cancer in 2014.
JOP. 2014 Mar 10;15(2):84-6. doi: 10.6092/1590-8577/2403.
7
Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice.
Recenti Prog Med. 2017 Mar;108(3):152-154. doi: 10.1701/2656.27239.
8
Incretin-based glucose-lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio-vascular outcome trials.
Diabetes Obes Metab. 2017 Sep;19(9):1327-1328. doi: 10.1111/dom.12981. Epub 2017 May 22.
9
From the guest editor please join us in this honorable quest.
Cancer J. 2012 Nov-Dec;18(6):475-6. doi: 10.1097/PPO.0b013e31827b0a7e.
10
Clinical effect and safety of dendritic cell-cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis.
Cytotherapy. 2019 Oct;21(10):1064-1080. doi: 10.1016/j.jcyt.2019.07.006. Epub 2019 Aug 26.
引用本文的文献
1
A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions.
Int J Mol Sci. 2024 Mar 3;25(5):2953. doi: 10.3390/ijms25052953.
2
Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL.
Cancer Res. 2022 Sep 16;82(18):3375-3393. doi: 10.1158/0008-5472.CAN-21-4222.
3
Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts.
Front Oncol. 2020 Oct 30;10:586727. doi: 10.3389/fonc.2020.586727. eCollection 2020.
本文引用的文献
1
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancreatic cancer patients (GrantPax).
BMC Cancer. 2018 Jul 18;18(1):747. doi: 10.1186/s12885-018-4665-2.
2
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma.
J Clin Oncol. 2018 Feb 1;36(4):359-366. doi: 10.1200/JCO.2017.74.9564. Epub 2017 Dec 12.
3
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results.
Oncologist. 2017 Dec;22(12):1429-e139. doi: 10.1634/theoncologist.2017-0472. Epub 2017 Nov 20.
4
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.
Oncologist. 2017 Dec;22(12):1427-e129. doi: 10.1634/theoncologist.2017-0066. Epub 2017 Sep 21.
5
Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer.
J Gastrointest Oncol. 2017 Jun;8(3):566-571. doi: 10.21037/jgo.2017.02.02.
6
Molecular Events in the Natural History of Pancreatic Cancer.
Trends Cancer. 2017 May;3(5):336-346. doi: 10.1016/j.trecan.2017.04.005. Epub 2017 May 10.
7
Current and Emerging Therapies in Metastatic Pancreatic Cancer.
Clin Cancer Res. 2017 Apr 1;23(7):1670-1678. doi: 10.1158/1078-0432.CCR-16-2319.
8
Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma".
Clin Cancer Res. 2017 Apr 1;23(7):1629-1637. doi: 10.1158/1078-0432.CCR-16-2070.
9
Pancreatic Cancer: Challenge and Inspiration.
Clin Cancer Res. 2017 Apr 1;23(7):1628. doi: 10.1158/1078-0432.CCR-16-2069.
10
Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysis.
Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):e26-e28. doi: 10.1016/j.clinre.2016.11.012. Epub 2017 Feb 17.
Zotero 插件